| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/25/2002 | WO2002057306A1 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions |
| 07/25/2002 | WO2002057304A2 Secretory molecules |
| 07/25/2002 | WO2002057302A2 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | WO2002057297A1 Use of zpr1 as a molecular probe for spinal muscular atrophy |
| 07/25/2002 | WO2002057290A2 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
| 07/25/2002 | WO2002056910A1 Binding domain-immunoglobulin fusion proteins |
| 07/25/2002 | WO2002056907A2 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | WO2002056905A2 Molecular antigen array |
| 07/25/2002 | WO2002056831A2 Immunogenic proteoliposomes, and uses thereof |
| 07/25/2002 | WO2002020830A3 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2002020039A3 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites |
| 07/25/2002 | WO2002014489A3 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 07/25/2002 | WO2002010196A3 Identification of a novel glutamine transporter |
| 07/25/2002 | WO2002004496A3 Fimh adhesin proteins and methods of use |
| 07/25/2002 | WO2002002642B1 Composition for pharmaceutical and cosmetic products |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001082788A3 Compounds and methods for the treatment and prevention of bacterial infection |
| 07/25/2002 | WO2001077332A3 Compositions and methods related to canine igg and canine il-13 receptors |
| 07/25/2002 | WO2001070798A3 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 07/25/2002 | WO2001060992A3 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 07/25/2002 | WO2001009187A9 Human monoclonal antibodies to her2/neu |
| 07/25/2002 | WO2001004157A9 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 07/25/2002 | WO2001002567A9 16405 receptor, a g-protein coupled receptor |
| 07/25/2002 | WO2001002001A9 PEPTIDE LIGANDS THAT BIND IgM ANTIBODIES AND BLOCK INTERACTION WITH ANTIGEN |
| 07/25/2002 | WO2001001150A9 Diagnostic test for thrombotic or thromboembolic disease |
| 07/25/2002 | WO2001000879A9 Novel kinases and uses thereof |
| 07/25/2002 | WO2001000829A9 Human endogenous retrovirus in breast cancer |
| 07/25/2002 | WO2001000812A9 22012, a novel human carboxypeptidase |
| 07/25/2002 | WO2001000811A9 17867, a novel human aminopeptidase |
| 07/25/2002 | US20020099199 Nucleotide sequences coding polypeptides for use in treatment of nervous system disorders; for use in learning enhancement |
| 07/25/2002 | US20020099181 Anti-fibroblast growth factor-8 monoclonal antibody |
| 07/25/2002 | US20020099180 Human FAP-alpha-specific antibodies |
| 07/25/2002 | US20020099179 Genetically engineered antibodies for use in the treatment of immunological defects |
| 07/25/2002 | US20020099178 Growth-associated protease inhibitor heavy chain precursor |
| 07/25/2002 | US20020099174 Filtration of plasma mixtures using cellulose-based filter aids |
| 07/25/2002 | US20020099169 Modulation of preferential transcription factor; obtain sample containing transcription factor, incubate with modulator, monitor transcriptional activity |
| 07/25/2002 | US20020099040 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 07/25/2002 | US20020099016 Feed or food for vertebrates including humans for inhibiting diarrhea |
| 07/25/2002 | US20020099012 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/25/2002 | US20020099009 Also diagnosing or detecting apoptosis as well as antibodies directed against the protein. |
| 07/25/2002 | US20020098597 Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| 07/25/2002 | US20020098583 Composition for use in the treatment of cell cycle defects, autoimmune diseases, aging, cancer, leukemia and psoriasis |
| 07/25/2002 | US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 07/25/2002 | US20020098580 MDM interacting protein and methods of use thereof |
| 07/25/2002 | US20020098551 From a hybrid cell formed from the fusion of two or more cells, each of which cell is engineered to express one component of the multimeric protein, as well as a method for screening for successful fusion of the cells |
| 07/25/2002 | US20020098550 Nucleotide sequences coding membrane protein for use in treatment and prevention of endotoxin shock, viral disease, immflammation and tumors |
| 07/25/2002 | US20020098544 Polypeptide for use in screening bactericides |
| 07/25/2002 | US20020098542 Novel forms of T cell costimulatory molecules and uses therefor |
| 07/25/2002 | US20020098540 Novel polypeptides, and nucleic acids encoding the same |
| 07/25/2002 | US20020098527 Gene recombinant antibody and antibody fragment thereof |
| 07/25/2002 | US20020098523 Binding ptoren for use in the treatment of asthma, eczema, rhinitis, conjunctivitis, allergies and gastrointestinal disorders |
| 07/25/2002 | US20020098521 Method and marker for the isolation of human multipotent hematopoietic stem cells |
| 07/25/2002 | US20020098520 Diagnosing preferential nervous system disorders; obtain protein sample, monitor g protein activity, adjustment in activity suggest nervous system disorder |
| 07/25/2002 | US20020098516 Diagnosing preferential genetic disorder in humans; obtain sample, incubate with antibody, detect bound antibody, compare to control, evaluate pattern for genetic disorder |
| 07/25/2002 | US20020098511 Polypeptide complexs for use in the diagnosis and treatment of non-insulin dependent diabetes mellitus and Alzheimer's Disease |
| 07/25/2002 | US20020098507 Nucleotide sequences coding polypeptide for use in human diagnostics and therapeutics; for use as biosensors |
| 07/25/2002 | US20020098506 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/25/2002 | US20020098505 Nucleotide sequences coding polypeptide for use in human diagnostics, therapeutics; for use as biosensors |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098193 Immunoglobin-like domains with increased half lives |
| 07/25/2002 | US20020098192 Polyalkylene oxide-modified single chain polypeptides |
| 07/25/2002 | US20020098191 Expression vector encoding a CD4-gamma2 chimeric heavy chain homodimer |
| 07/25/2002 | US20020098190 Delaying development of HMFG- and CEA- associated tumor by administering first antibody comprising light and heavy chain variable region sequences in SEQ ID NO:2 and NO:4, and second antibody comprising sequences in SEQ ID NO:6 and NO:8 |
| 07/25/2002 | US20020098189 Have specificity for antigens displayed by microorganisms, especially viruses, as well as antigenic sites present on cancer cells and on various types of toxins, and products of toxins |
| 07/25/2002 | US20020098187 Vascular endothelial cell growth factor antagonists |
| 07/25/2002 | US20020098184 Comprising T-cell dependant antigen, or part thereof, and associated adjuvant which is adapted to stimulate T-cell lymphocyte via cell surface receptor CD28 |
| 07/25/2002 | US20020098183 Administering anti-L-selectin antibody in pharmaceutically acceptable carrier to patient in amount sufficient to reduce multiple organ failure, wherein first dose is administered from 0.5 to 8 hours after polytraumatic event |
| 07/25/2002 | US20020098182 Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G |
| 07/25/2002 | US20020098181 Inoculating female birds in egg laying age with targeted colony-forming immunogen, allowing time sufficient to permit production in bird of antibody, harvesting eggs, separating antibody-containing contents |
| 07/25/2002 | US20020098177 17867, a novel human aminopeptidase |
| 07/25/2002 | US20020098163 Isolated nucleic acid molecules used for immunotherapy |
| 07/25/2002 | DE10102337A1 Preparing ester containing polyunsaturated fatty acids, useful e.g. in animal or human nutrition, by transforming organism with desaturase gene from Phaeodactylum tricornatum |
| 07/25/2002 | CA2447606A1 Ternary biomolecule/polymer/surface-based immobilization systems |
| 07/25/2002 | CA2437082A1 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 07/25/2002 | CA2435260A1 Receptors and membrane-associated proteins |
| 07/25/2002 | CA2435180A1 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | CA2435081A1 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs |
| 07/25/2002 | CA2435037A1 Bifunctional fusion proteins with glucocerebrosidase activity |
| 07/25/2002 | CA2434928A1 Genes |
| 07/25/2002 | CA2434802A1 Isolating cells expressing secreted proteins |
| 07/25/2002 | CA2434490A1 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions |
| 07/25/2002 | CA2434099A1 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
| 07/25/2002 | CA2433862A1 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | CA2433802A1 Secretory molecules |
| 07/25/2002 | CA2433394A1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 07/25/2002 | CA2433316A1 Molecular antigen array |
| 07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
| 07/25/2002 | CA2432041A1 Polynucleotides encoding human phosphatases |
| 07/25/2002 | CA2431212A1 Immunogenic proteoliposomes, and uses thereof |
| 07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | CA2429942A1 Hydrolase enzymes and their use in kinetic resolution |
| 07/25/2002 | CA2427643A1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 07/25/2002 | CA2406342A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 07/24/2002 | EP1225226A1 Peptides and nucleic acid sequences related to Epstein Barr Virus |
| 07/24/2002 | EP1225225A2 Osteogenic devices |
| 07/24/2002 | EP1225224A1 Shear stress-response dna |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
| 07/24/2002 | EP1225180A2 Process for the production of virus-inactivated human gammaglobulin G |
| 07/24/2002 | EP1224943A1 Fibronectin as a tumor marker detected by phage antibodies |